A growing number of long non-coding RNAs (lncRNAs) have been linked to squamous cell carcinoma of the head and neck (SCCHN). A subclass of lncRNAs, termed enhancer RNAs (eRNAs), are derived from enhancer regions and could contribute to enhancer function. In this study, we developed an integrated data analysis approach to identify key eRNAs in SCCHN. Tissue-specific enhancer-derived RNAs and their regulated genes previously predicted using the computational pipeline PreSTIGE, were considered as putative eRNA-target pairs. The interactive web servers, TANRIC (the Atlas of Noncoding RNAs in Cancer) and cBioPortal, were used to explore the RNA levels and clinical data from the Cancer Genome Atlas (TCGA) project. Requiring that key eRNAs should show significant associations with overall survival (Kaplan⁻Meier log-rank test, p < 0.05) and the predicted target (correlation coefficient r > 0.4, p < 0.001), we identified five key eRNA candidates. The most significant survival-associated eRNA was AP001056.1 with ICOSLG encoding an immune checkpoint protein as its regulated target. Another 1640 genes also showed significant correlation with AP001056.1 (r > 0.4, p < 0.001), with the "immune system process" being the most significantly enriched biological process (adjusted p < 0.001). Our results suggest that AP001056.1 is a key immune-related eRNA in SCCHN with a positive impact on clinical outcome.

Department of Clinical Sciences ENT Umeå University 90185 Umeå Sweden

Department of Medical Biosciences Pathology Umeå University 90185 Umeå Sweden

Équipe Labellisée Ligue Contre le Cancer INSERM UMRS1162 Institut de Génétique Moléculaire Université Paris 7 IUH Hôpital St Louis 75010 Paris France

RECAMO Masaryk Memorial Cancer Institute 656 53 Brno Czech Republic

Zobrazit více v PubMed

Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018 doi: 10.3322/caac.21492. PubMed DOI

Spence T., Bruce J., Yip K.W., Liu F.F. HPV associated head and neck cancer. Cancers. 2016;8:75. doi: 10.3390/cancers8080075. PubMed DOI PMC

Leemans C.R., Snijders P.J.F., Brakenhoff R.H. The molecular landscape of head and neck cancer. Nat. Rev. Cancer. 2018;18:269–282. doi: 10.1038/nrc.2018.11. PubMed DOI

Arun G., Diermeier S.D., Spector D.L. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol. Med. 2018;24:257–277. doi: 10.1016/j.molmed.2018.01.001. PubMed DOI PMC

Atianand M.K., Caffrey D.R., Fitzgerald K.A. Immunobiology of long noncoding RNAs. Annu. Rev. Immunol. 2017;35:177–198. doi: 10.1146/annurev-immunol-041015-055459. PubMed DOI PMC

Kopp F., Mendell J.T. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393–407. doi: 10.1016/j.cell.2018.01.011. PubMed DOI PMC

Ransohoff J.D., Wei Y., Khavari P.A. The functions and unique features of long intergenic non-coding RNA. Nat. Rev. Mol. Cell. Biol. 2018;19:143–157. doi: 10.1038/nrm.2017.104. PubMed DOI PMC

Iyer M.K., Niknafs Y.S., Malik R., Singhal U., Sahu A., Hosono Y., Barrette T.R., Prensner J.R., Evans J.R., Zhao S., et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015;47:199–208. doi: 10.1038/ng.3192. PubMed DOI PMC

Song W., Sun Y., Lin J., Bi X. Current research on head and neck cancer-associated long noncoding RNAs. Oncotarget. 2018;9:1403–1425. doi: 10.18632/oncotarget.22608. PubMed DOI PMC

Nohata N., Abba M.C., Gutkind J.S. Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection. Oral Oncol. 2016;59:58–66. doi: 10.1016/j.oraloncology.2016.05.014. PubMed DOI PMC

Natoli G., Andrau J.C. Noncoding transcription at enhancers: General principles and functional models. Annu. Rev. Genet. 2012;46:1–19. doi: 10.1146/annurev-genet-110711-155459. PubMed DOI

Chen H.J., Du G.S., Song X., Li L. Non-coding transcripts from enhancers: New insights into enhancer activity and gene expression regulation. Genom. Proteom. Bioinform. 2017;15:201–207. doi: 10.1016/j.gpb.2017.02.003. PubMed DOI PMC

Fang Y., Fullwood M.J. Roles, functions, and mechanisms of long non-coding RNAs in Cancer. Genom. Proteom. Bioinform. 2016;14:42–54. doi: 10.1016/j.gpb.2015.09.006. PubMed DOI PMC

Liu Y., Ding M., Gao Q., He A., Liu Y., Mei H. Current advances on the important roles of enhancer RNAs in gene regulation and cancer. Biomed. Res. Int. 2018;2018:2405351. doi: 10.1155/2018/2405351. PubMed DOI PMC

Bal E., Park H.S., Belaid-Choucair Z., Kayserili H., Naville M., Madrange M., Chiticariu E., Hadj-Rabia S., Cagnard N., Kuonen F., et al. Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas. Nat. Med. 2017;23:1226–1233. doi: 10.1038/nm.4368. PubMed DOI

Irimie A.I., Zimta A.A., Ciocan C., Mehterov N., Dudea D., Braicu C., Berindan-Neagoe I. The unforeseen non-coding RNAs in head and neck cancer. Genes. 2018;9:134. doi: 10.3390/genes9030134. PubMed DOI PMC

Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74. doi: 10.1038/nature11247. PubMed DOI PMC

Vucicevic D., Corradin O., Ntini E., Scacheri P.C., Orom U.A. Long ncRNA expression associates with tissue-specific enhancers. Cell Cycle. 2015;14:253–260. doi: 10.4161/15384101.2014.977641. PubMed DOI PMC

Mascitti M., Rubini C., De Michele F., Balercia P., Girotto R., Troiano G., Lo Muzio L., Santarelli A. American Joint Committee on Cancer staging system 7th edition versus 8th edition: Any improvement for patients with squamous cell carcinoma of the tongue? Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. 2018;126:415–423. doi: 10.1016/j.oooo.2018.07.052. PubMed DOI

Nurieva R.I., Mai X.M., Forbush K., Bevan M.J., Dong C. B7h is required for T cell activation, differentiation, and effector function. Proc. Natl. Acad. Sci. USA. 2003;100:14163–14168. doi: 10.1073/pnas.2335041100. PubMed DOI PMC

Wood O., Woo J., Seumois G., Savelyeva N., McCann K.J., Singh D., Jones T., Peel L., Breen M.S., Ward M., et al. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget. 2016;7:56781–56797. doi: 10.18632/oncotarget.10788. PubMed DOI PMC

Loizou C., Laurell G., Lindquist D., Öfverman C., Stefansson K., Nylander K., Olofsson K. Incidence of tonsillar cancer in northern Sweden: Impact of human papilloma virus. Oncol. Lett. 2015 doi: 10.3892/ol.2015.3775. PubMed DOI PMC

Corradin O., Saiakhova A., Akhtar-Zaidi B., Myeroff L., Willis J., Cowper-Sal lari R., Lupien M., Markowitz S., Scacheri P.C. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 2014;24:1–13. doi: 10.1101/gr.164079.113. PubMed DOI PMC

Li J., Han L., Roebuck P., Diao L., Liu L., Yuan Y., Weinstein J.N., Liang H. TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Res. 2015;75:3728–3737. doi: 10.1158/0008-5472.CAN-15-0273. PubMed DOI PMC

Gao J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., Sun Y., Jacobsen A., Sinha R., Larsson E., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013;6:pl1. doi: 10.1126/scisignal.2004088. PubMed DOI PMC

Khatri P., Draghici S. Ontological analysis of gene expression data: Current tools, limitations, and open problems. Bioinformatics. 2005;21:3587–3595. doi: 10.1093/bioinformatics/bti565. PubMed DOI PMC

Eden E., Navon R., Steinfeld I., Lipson D., Yakhini Z. GOrilla: A tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 2009;10:48. doi: 10.1186/1471-2105-10-48. PubMed DOI PMC

Boldrup L., Gu X., Coates P.J., Norberg-Spaak L., Fahraeus R., Laurell G., Wilms T., Nylander K. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma. Oncotarget. 2017;8:19389–19402. doi: 10.18632/oncotarget.14288. PubMed DOI PMC

Gu X., Boldrup L., Coates P.J., Fahraeus R., Nylander E., Loizou C., Olofsson K., Norberg-Spaak L., Garskog O., Nylander K. Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites. Sci. Rep. 2016;6:32579. doi: 10.1038/srep32579. PubMed DOI PMC

Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: Implications for treatment